Synthesis of some novel pyrimidine, thiophene, coumarin, pyridine and pyrrole derivatives and their biological evaluation as analgesic, antipyretic and anti-inflammatory agents
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | El-Sharkawy K.A. | |
dc.contributor.author | AlBratty M.M. | |
dc.contributor.author | Alhazmi H.A. | |
dc.contributor.other | Department of Pharmaceutical Chemistry | |
dc.contributor.other | College of pharmacy | |
dc.contributor.other | Jazan University | |
dc.contributor.other | Jazan | |
dc.contributor.other | 45142 | |
dc.contributor.other | Saudi Arabia; Department of Chemistry | |
dc.contributor.other | Faculty of Biotechnology | |
dc.contributor.other | October University for Modern Sciences and Arts(MSA) | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:41:00Z | |
dc.date.available | 2020-01-09T20:41:00Z | |
dc.date.issued | 2018 | |
dc.description | Scopus | |
dc.description.abstract | Pyrimidine derivative 3 was afforded through the reaction of compound (1) with 5-ureidohydantion (2). Product 3 underwent a cyclization to produce fused pyrimidine derivative 7, although the latter product 7 was synthesized through one step via the reaction of compound (1) with 5-ureidohydantion (2) using another catalyst. Compound 3 was oriented to react with cyclic ketones 8a,b in the presence of elemental sulfur, salicylaldehyde (10), aryldiazonium chlorides 12a,b and ?-bromo-4-methoxy- acetophenone (14), which afforded, fused thiophene derivatives 9a,b, coumarin derivative 11, arylhdrazono derivatives 13a,b and 4-methoxyphenyl butenyl derivative 15, respectively. The latter product 15 was reacted with either potassium cyanide (16a) or potassium thiocyanide (16b) to form cyano and thiocyano derivatives 17a,b, respectively. Compound 17a underwent further cyclization to afford pyridopyrimidine derivative 19. Compound 15 was reacted with either hydrazine (20a) or phenylhydrazine (20b) to produce hydrazo derivatives 21a,b and these products were cyclize to produce pyrrole derivatives 23a,b. Finally, 5-ureidohydantion (2) was reacted with compounds 24a,b,c to afford pyrimidine derivatives 25a,b,c. The structures of the synthesized compounds were confirmed using IR, 1H NMR, 13C NMR and mass spectrometry techniques. Compounds 11 and 19 have promising as analgesic and antipyretic activities. � 2019, Faculdade de Ciencias Farmaceuticas (Biblioteca). All rights reserved. | en_US |
dc.identifier.doi | https://doi.org/10.1590/s2175-97902018000400153 | |
dc.identifier.doi | PubMedID | |
dc.identifier.issn | 19848250 | |
dc.identifier.other | https://doi.org/10.1590/s2175-97902018000400153 | |
dc.identifier.other | PubMedID | |
dc.identifier.uri | https://t.ly/germm | |
dc.language.iso | English | en_US |
dc.publisher | Taylor and Francis Ltd. | |
dc.publisher | Faculdade de Ciencias Farmaceuticas (Biblioteca) | en_US |
dc.relation.ispartofseries | Brazilian Journal of Pharmaceutical Sciences | |
dc.relation.ispartofseries | 54 | |
dc.subject | October University for Modern Sciences and Arts | |
dc.subject | جامعة أكتوبر للعلوم الحديثة والآداب | |
dc.subject | University of Modern Sciences and Arts | |
dc.subject | MSA University | |
dc.subject | Analgesic | en_US |
dc.subject | Antipyretic and anti-inflammatory agents | en_US |
dc.subject | Coumarin | en_US |
dc.subject | Pyridine | en_US |
dc.subject | Pyrimidine derivative | en_US |
dc.subject | Pyrrole | en_US |
dc.subject | Thiophene | en_US |
dc.subject | 2 ((4,6 diamino 1 (2,5 dioxo imidazol idin 4 yl) 2 oxo 1,2 dihydropyrimidin 5 yl) (imino) methyl) 3 (4 methoxy phenyl) 4 (2 phenyl hydrazinyl)but 2 enenitrile | en_US |
dc.subject | 2 ((4,6 diamino 1 (2,5 dioxo imidazolidin 4 yl) 2 oxo 1,2 dihydropyrimidin 5 yl) (imino) methyl) 4 hydrazinyl 3 (4 methoxyphenyl)but 2 enenitrile | en_US |
dc.subject | 2 (4,6 diamino 1 (2,5 dioxo imidazolidin 4 yl) 2 oxo1,2 dihydropyrimidin 5 yl) 2 imino N� phenylacetohydrazonoylcyanide | en_US |
dc.subject | 3 (4,6 diamino 1 (2,5 dioxoimidazolidin 4 yl) 2 oxo 1,2 dihydropyrimidin 5 yl) 3 iminopropanenitrile | en_US |
dc.subject | 4 bromo 2 ((4,6 diamino 1 (2,5 dioxo imidazolidin 4 yl) 2 oxo 1,2 dihydropyrimidin 5 yl) (imino) methyl) 3 (4 methoxyphenyl)but 2 enenitrile | en_US |
dc.subject | 5 (4 amino 5 (2 (4 chlorophenyl)hydrazono) 6 imino 2 oxo 5,6 dihydro pyrimidin 1(2h) yl)imidazolidine 2,4 dione | en_US |
dc.subject | 5 (4 amino 6 imino 2 oxo 5 (1 phenylethylidene) 5,6 dihydropyrimidin 1(2h) yl)imidazolidine 2,4 dione | en_US |
dc.subject | 5 (4 amino 6 imino 2 oxo 5 (2 phenylhydrazono 5,6 dihydropyrimidin 1(2h) yl) imidazol idine 2,4 dione | en_US |
dc.subject | 5 (4,5,7 triamino 2 oxopyrido [2,3 d]pyrimidin 3(2h) yl)imidazolidine 2,4 dione | en_US |
dc.subject | 5 (4,6 diamino 5 ((1,2 diamino 4 (4 methoxyphenyl) 1h pyrrol 3 yl) (imino)methyl) 2 oxopyrimidin 1(2h) yl)imidazolidine 2,4 dione | en_US |
dc.subject | 5 (4,6 diamino 5 ((2 amino 4 (4 methoxyphenyl) 1 (phenylamino) 1hpyrrol 3 yl)(imino)methyl) 2 oxopyrimidin 1(2h) yl)imidazolidine 2,4 dione | en_US |
dc.subject | 5 (4,6 diamino 5 ((2 amino 4,5,6,7 tetrahydrobenzo[b]thiophen 3 yl(imino) methyl) 2 oxopyrimidin 1(2h)yl) imidazolidine 2,4 dione | en_US |
dc.subject | 5 (4,6 diamino 5 ((2 amino 5,6 dihydro 4hcyclopenta[b]thiophen 3 yl)(imino)methyl) 2 oxopyrimidin 1(2h) yl) imidazolidine 2,4 dione | en_US |
dc.subject | 5 (4,6 diamino 5 (imino(2 oxo 2h chromen 3 yl)methyl) 2 oxopyrimidin 1(2h) yl)imidazolidine 2,4 dione | en_US |
dc.subject | coumarin derivative | en_US |
dc.subject | N� (4 chlorophenyl) 2 (4,6 diamino 1 (2,5 dioxo imidazolidin 4 yl 2 oxo 1,2 dihydropyrimidin 5 yl) 2 iminoaceto hydrazonoylcyanide | en_US |
dc.subject | paracetamol | en_US |
dc.subject | pyridine derivative | en_US |
dc.subject | pyrimidine derivative | en_US |
dc.subject | pyrrole derivative | en_US |
dc.subject | thiophene derivative | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | analgesic activity | en_US |
dc.subject | animal experiment | en_US |
dc.subject | animal model | en_US |
dc.subject | antiinflammatory activity | en_US |
dc.subject | antipyretic activity | en_US |
dc.subject | Article | en_US |
dc.subject | carbon nuclear magnetic resonance | en_US |
dc.subject | controlled study | en_US |
dc.subject | experimental paw edema | en_US |
dc.subject | infrared spectroscopy | en_US |
dc.subject | mass spectrometry | en_US |
dc.subject | mouse | en_US |
dc.subject | nonhuman | en_US |
dc.subject | proton nuclear magnetic resonance | en_US |
dc.subject | rat | en_US |
dc.subject | tail flick test | en_US |
dc.title | Synthesis of some novel pyrimidine, thiophene, coumarin, pyridine and pyrrole derivatives and their biological evaluation as analgesic, antipyretic and anti-inflammatory agents | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Agarwal, A., Ashutosh, R., Goyal, N., Chawhan, P.M.S., Gupta, S., Dihydropyrido [2,3-d]pyrimidines as a new class of antileishmanial agents (2005) Bioorg Med Chem., 13 (24), pp. 6678-6684; Dallemagne, P., Khanh, L.P., Alsaidi, A., Varlet, I., Collot, V., Paillet, M., Bureau, R., Rault, S., Synthesis and biological evaluation of five-Membered heterocycles fused to cyclopenta[c]thiophene as new antitumor agents (2003) Bioorg Med Chem., 11 (7), pp. 1161-1167; El-Sharkawy, K.A., Nasser, N.E., Zaki, M.Y., Uses of 2-Amino-5, 6-dihydro-4H-cyclopenta [b] thiophene-3-carbonitrile in the synthesis of novel heterocyclic compounds with anticonvulsant, behavioral and CNS antidepressant activities (2012) Int Res J Pure App Chem., 2 (1), pp. 91-104; Fadeyi, O.O., Obafemi, C.A., Adewunmi, C.O., Iwalewa, E.O., Antipyretic, analgesic, anti-inflammatory and cytotoxic effects of four derivatives of salicylic acid and anthranilic acid in mice and rats (2004) Afr J Biotech., 3 (8), pp. 426-431; Gus�Kov, E.P., Prokofev, V.N., Kletskii, M.E., Kornienko, I.V., Ogapurenko, A., Olekhnovich, L.P., Chistyakov, V.A., Sazykina, M.A., Allantoin as a vitamin (2004) Dokl Biochem Biophys., 398, pp. 320-324; Horvati, K., Bacasa, B., Szabo, N., Fodor, K., Balaka, G., Rusavai, M., �, K., Bosze, S., Antimycobacterial activity of peptide conjugate of pyridopyrimidine derivative against Mycobacterium tuberculosis in a series of in vitro and in vivo models (2015) Tuberculosis., 95, pp. S207-S211; Iqbal, Z., Hameed, S., Ali, S., Tehseen, Y., Shahid, M., Iqbal, J., Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5?- imidazolidine]-2?,4?-diones (2015) Eur J Med Chem., 98, pp. 127-138; Keri, R.S., Hosamani, K.M., Shingalapure, R.V., Hugar, M.H., Analgesic, anti-pyretic and DNA cleavage studies of novel pyrimidine derivatives of coumarin moiety (2010) Eur J Med Chem., 45 (6), pp. 2597-2605; Kulkarni, S.K., (2003) Handbook of Experimental Pharmacology., pp. 123-125 and 128-131 and 172-186. , 3 ed. Delhi: Vallabh Prakashan; Mohareb, R., El-Sharkawy, K.A., Sherif, S.M., The reaction of ?-amino-?,?-dicyano -crotononitrile with acetophenone:Synthesis of pyridine, pyridazine and thiophene derivatives with antimicrobial activities (2008) Acta Pharm., 58, pp. 429-444; Padmavathi, V., Prema Kumari, C., Venkatesh, B.C., Padmaja, A., Synthesis and antimicrobial activity of amido linked pyrrolyl and pyrazolyl-oxazoles, thiazoles and imidazoles (2011) Eur J Med Chem., 46 (11), pp. 5317-5326; Rajesh, S.M., Kumar, R.S., Libertsen, L.A., Perumal, S., Yogeeswari, P., Sriram, D., A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity (2011) Bioorg Med Chem Lett., 21 (10), pp. 3012-3016; Reddy, Y.T., Reddy, P.N., Kodru, S., Damodran, C., Crooks, P.A., Aplysinopsin analogs: Synthesis and anti-proliferative activity of substituted (Z)-5-(N-benzylindol-3-ylmethylene) imidazolidine-2,4-diones (2010) Bioorg Med Chem., 18 (10), pp. 3570-3574; Sztanke, M., Rzymowska, J., Sztanke, K., Synthesis, structure elucidation and in vitro anticancer activities of novel derivatives of diethyl (2E)-2-[(2E)-(1-aryl- imidazolidin-2-ylidene) hydrazono]succinate and ethyl (4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[ 2,1-c][1,2,4]triazin-3-yl)acetate (2013) Bioorg Med Chem., 21 (23), pp. 7465-7480; Vogel, H.G., Drug discovery and evaluation (2002) Pharmacological assay., pp. 695-696 and 759-762 and 772-773. , 2 ed. Berlin, Heidelberg: Springer-Verlag; Wang, G., Wang, Y., Wang, L., Han, L., Hou, X., Fu, H., Fang, H., Design, synthesis and preliminary bioactivity studies of imidazolidine-2,4-dione derivatives as Bcl-2 inhibitors (2015) Bioorg Med Chem., 23 (23), pp. 7359-7365 | |
dcterms.source | Scopus |